NYSEARCA:PBEInvesco Dynamic Biotechnology & Genome ETF Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Invesco Dynamic Biotechnology & Genome ETF Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $57.25 +0.04 (+0.07 %) (As of 05/29/2020 03:29 PM ET) Add Share Today's Range$56.46Now: $57.25▼$57.3050-Day Range$46.99MA: $54.00▼$58.6552-Week Range$38.08Now: $57.25▼$60.00Volume6,457 shsAverage Volume12,641 shsMarket Capitalization$237.59 millionP/E RatioN/ADividend Yield0.05%BetaN/A ProfileAdvanced ChartDividendInstitutional OwnershipHeadlinesSocial Media PowerShares Dynamic Biotechnology & Genome Portfolio (the Fund) is based on the Dynamic Biotechnology & Genome Intellidex Index (the Index). The Fund seeks investment results that correspond generally to the price and yield of the Index. The Index consists of stocks of 30 the United States biotechnology and genome companies. The Fund will normally invest at least 90% of its total assets in common stocks that consists of the Index. The Index is designed to provide capital appreciation by evaluating companies based on a variety of investment merit criteria, including fundamental growth, stock valuation, investment timeliness and risk factors. Invesco PowerShares Capital Management LLC acts as the Fund's investment adviser.Read More Beat the Market (BTM) Rank™ 0.0 Analyst's Opinion Consensus RatingThere is not enough analysis data for Invesco Dynamic Biotechnology & Genome ETF. Previous Next 2.6 Community Rank Outperform VotesInvesco Dynamic Biotechnology & Genome ETF has received 39 “outperform” votes. (Add your “outperform” vote.)Underperform VotesInvesco Dynamic Biotechnology & Genome ETF has received 35 “underperform” votes. (Add your “underperform” vote.)Community SentimentInvesco Dynamic Biotechnology & Genome ETF has received 52.70% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Invesco Dynamic Biotechnology & Genome ETF and other stocks. Vote “Outperform” if you believe PBE will outperform the S&P 500 over the long term. Vote “Underperform” if you believe PBE will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 1.7 Dividend Strength Dividend LeadershipInvesco Dynamic Biotechnology & Genome ETF is a leading dividend payer. It pays a dividend yield of 0.05%, putting its dividend yield in the top 25% of dividend-paying stocks.Dividend GrowthInvesco Dynamic Biotechnology & Genome ETF does not have a long track record of dividend growth. Previous Next 0.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Invesco Dynamic Biotechnology & Genome ETF insiders have not sold or bought any company stock. Previous Next 0.0 Earnings and Valuation Previous Next Analyst Opinion: 0.0Community Rank: 2.6Dividend Strength: 1.7Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -Overall Beat the Market Rank™0.85 out of 5 stars Basic Details Issuer Invesco Fund NameInvesco Dynamic Biotechnology & Genome ETF Tax ClassificationRegulated Investment Company SymbolNYSEARCA:PBE Inception Date6/23/2005 Fund ManagerPeter Hubbard, Michael Jeanette, Tony Seisser, Jonathan Nixon Webwww.invescopowershares.com Phone+1-800-9830903 Fund Focus Asset ClassEquity BenchmarkDynamic Biotechnology & Genome Intellidex Index CategorySector FocusHealth Care Development LevelDeveloped Markets RegionNorth America Fund Statistics Assets Under Management$238.09 million Average Daily Volume$12,820.50 Discount/Premium0.04% ETF Expenses Management Fee0.50% Other Expenses0.08% Total Expenses0.58% Fee Waiver0.00% Net Expenses0.58%Administrator, Advisor and Custodian AdministratorThe Bank of New York Mellon Corporation AdvisorInvesco Capital Management LLC CustodianThe Bank of New York Mellon Corporation DistributorInvesco Distributors, Inc. Transfer AgentThe Bank of New York Mellon Corporation Trustee Lead Market MakerCitadel AMEX:PBE Rates by TradingView Receive PBE News and Ratings via Email Sign-up to receive the latest news and ratings for PBE and its competitors with MarketBeat's FREE daily newsletter. Invesco Dynamic Biotechnology & Genome ETF (NYSEARCA:PBE) Frequently Asked Questions How has Invesco Dynamic Biotechnology & Genome ETF's stock been impacted by COVID-19 (Coronavirus)? Invesco Dynamic Biotechnology & Genome ETF's stock was trading at $45.90 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, PBE stock has increased by 24.7% and is now trading at $57.2511. View which stocks have been most impacted by Coronavirus. Has Invesco Dynamic Biotechnology & Genome ETF been receiving favorable news coverage? Media stories about PBE stock have trended somewhat negative on Friday, according to InfoTrie Sentiment Analysis. The research group ranks the sentiment of news coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Invesco Dynamic Biotechnology & Genome ETF earned a media sentiment score of -1.6 on InfoTrie's scale. They also gave media coverage about the company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the stock's share price in the next several days. View the latest news aboutInvesco Dynamic Biotechnology & Genome ETF. What other stocks do shareholders of Invesco Dynamic Biotechnology & Genome ETF own? Based on aggregate information from My MarketBeat watchlists, some companies that other Invesco Dynamic Biotechnology & Genome ETF investors own include Align Technology (ALGN), Activision Blizzard (ATVI), Netflix (NFLX), Boeing (BA), Mastercard (MA), Micron Technology (MU), NVIDIA (NVDA), Paypal (PYPL), Visa (V) and Wayfair (W). Who are Invesco Dynamic Biotechnology & Genome ETF's key executives? Invesco Dynamic Biotechnology & Genome ETF's management team includes the following people: H. Bruce Bond, Chairman of the Board of Trustee, Chief Executive OfficerBruce T. Duncan, Chief Financial Officer, TreasurerKevin R. Gustafson, Chief Compliance OfficerKeith A Ovitt, SecretaryRonn R. Bagge, TrusteeMarc M Kole, TrusteeD. Mark McMillan, TrusteePhilip M. Nussbaum Mba, TrusteeDonald H. Wilson, Trustee What is Invesco Dynamic Biotechnology & Genome ETF's stock symbol? Invesco Dynamic Biotechnology & Genome ETF trades on the New York Stock Exchange (NYSE)ARCA under the ticker symbol "PBE." Who are Invesco Dynamic Biotechnology & Genome ETF's major shareholders? Invesco Dynamic Biotechnology & Genome ETF's stock is owned by a variety of retail and institutional investors. Top institutional investors include Morgan Stanley (3.25%), Morgan Stanley (3.25%), Advisor Group Holdings Inc. (1.66%), UBS Group AG (1.55%), Wells Fargo & Company MN (1.19%) and Institute for Wealth Management LLC. (0.52%). Which institutional investors are selling Invesco Dynamic Biotechnology & Genome ETF stock? PBE stock was sold by a variety of institutional investors in the last quarter, including UBS Group AG, Wells Fargo & Company MN, Wharton Business Group LLC, Janney Montgomery Scott LLC, Investment House LLC, MML Investors Services LLC, Morgan Stanley, and Morgan Stanley. Which institutional investors are buying Invesco Dynamic Biotechnology & Genome ETF stock? PBE stock was acquired by a variety of institutional investors in the last quarter, including Advisor Group Holdings Inc., Capital One Financial Corp, Jane Street Group LLC, Raymond James Financial Services Advisors Inc., Steward Partners Investment Advisory LLC, JPMorgan Chase & Co., HighTower Advisors LLC, and Citigroup Inc.. How do I buy shares of Invesco Dynamic Biotechnology & Genome ETF? Shares of PBE can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Invesco Dynamic Biotechnology & Genome ETF's stock price today? One share of PBE stock can currently be purchased for approximately $57.25. How big of a company is Invesco Dynamic Biotechnology & Genome ETF? Invesco Dynamic Biotechnology & Genome ETF has a market capitalization of $237.59 million. What is Invesco Dynamic Biotechnology & Genome ETF's official website? The official website for Invesco Dynamic Biotechnology & Genome ETF is www.invescopowershares.com. How can I contact Invesco Dynamic Biotechnology & Genome ETF? Invesco Dynamic Biotechnology & Genome ETF's mailing address is 301 West Roosevelt Road, WHEATON, IL 60187, United States. The company can be reached via phone at +1-800-9830903. This page was last updated on 5/29/2020 by MarketBeat.com Staff
